Cutler Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-809
Closed -$576K 3020
2023
Q4
$471K Sell
809
-362
-31% -$211K 0.04% 441
2023
Q3
$628K Sell
1,171
-231
-16% -$119K 0.06% 362
2023
Q2
$657K Buy
+1,402
New +$588K 0.09% 253
2023
Q1
Sell
-6,143
Closed -$2.07M 4317
2022
Q4
$2.25M Buy
6,143
+763
+14% +$271K 0.19% 115
2022
Q3
$1.74M Sell
5,380
-11,116
-67% -$3.52M 0.12% 181
2022
Q2
$5.35M Buy
16,496
+16,253
+6,688% +$4.88M 0.37% 41
2022
Q1
$69K Sell
243
-23,927
-99% -$6.16M ﹤0.01% 1985
2021
Q4
$6.68M Buy
24,170
+23,696
+4,999% +$6.01M 0.28% 60
2021
Q3
$109K Buy
+474
New +$117K ﹤0.01% 1847
2019
Q2
Sell
-200
Closed -$23.6K 4563
2019
Q1
$25K Buy
+200
New +$24.3K ﹤0.01% 1878
2018
Q1
Sell
-667
Closed -$53.7K 4879
2017
Q4
$56K Buy
+667
New +$56.8K ﹤0.01% 1782
2017
Q3
Sell
-2,374
Closed -$195K 6314
2017
Q2
$195K Buy
2,374
+353
+17% +$28.8K 0.01% 1305
2017
Q1
$169K Sell
2,021
-133,132
-99% -$10.7M 0.01% 1313
2016
Q4
$9.94M Buy
135,153
+118,102
+693% +$8.8M 0.36% 31
2016
Q3
$1.37M Sell
17,051
-2,149
-11% -$172K 0.06% 229
2016
Q2
$1.51M Buy
19,200
+15,224
+383% +$1.15M 0.08% 186
2016
Q1
$286K Sell
3,976
-1,104
-22% -$83.5K 0.02% 797
2015
Q4
$428K Buy
+5,080
New +$422K 0.02% 705

Other funds holding LLY

Cutler Group's LLY Position: Q1 2024 in Review

Cutler Group sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 809 shares — an estimated $576K sold.

Cutler Group first reported a position in LLY in Q4 2015 and held it in 18 quarters. The position peaked at $9.94M in Q4 2016. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Cutler Group reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 809 Eli Lilly shares in Q1 2024, an estimated $576K.
  • Cutler Group first reported a position in Eli Lilly in Q4 2015 and held it in 18 quarters.
  • Cutler Group's Eli Lilly position peaked at $9.94M in Q4 2016.
  • 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.